Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

Author: Ghiringhelli François   Menard Cedric   Puig Pierre   Ladoire Sylvain   Roux Stephan   Martin François   Solary Eric   Le Cesne Axel   Zitvogel Laurence   Chauffert Bruno  

Publisher: Springer Publishing Company

ISSN: 0340-7004

Source: Cancer Immunology, Immunotherapy, Vol.56, Iss.5, 2007-05, pp. : 641-648

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content